Skip to content

Clinical trials

Completed Bipolar Disorder trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Status: Completed Country / region: China Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20062
20071
20081
20091
20101
20122
20131
20151
20173
20181
20202
20211
20222
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
First Affiliated Hospital of Zhejiang University4
Shanghai Mental Health Center3
Central South University2
China Medical University, China2
Eli Lilly and Company2
GlaxoSmithKline2
Guangzhou Psychiatric Hospital1
Islamic Azad University, Sanandaj1
Janssen Pharmaceutica N.V., Belgium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder24
Cognitive Dysfunction3
Schizophrenia3
Mania2
Depressive Disorder1
Major Depressive Disorder1
Mental Disorders1
Metabolic Syndrome1
Mood Disorders1
Multiple Sclerosis1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.